Last checked at 
LONDON, March 2 (Reuters) - Real-world data on the
effectiveness of Oxford and AstraZeneca's COVID-19
vaccine in older people from its rollout in Britain should help
inform decision making in other countries, Oxford Vaccine Group
Director Andrew Pollard said on Tuesday.
Asked if other countries should look at real world data from
Public Health England, Pollard said: "I think that the
scientific committees in each of these countries will be doing
exactly that over the days ahead.
"The strength of evidence that we're now seeing... all of
that is being accessed by scientific committees in different
countries, and I'm sure will help support their decision
making," he told BBC radio.
(Reporting by Alistair Smout; editing by Michael Holden)
